Browsing by Author Tonkin, Andrew

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 20 of 44  next >
Issue DateTitleAuthor(s)Citation
2011Accumulation of microplastic on shorelines woldwide: Sources and sinksBrowne, Mark; Crump, Phillip; Galloway, Tamara; Niven, Stewart; Teuten, Emma; Thompson, Richard C; Tonkin, Andrew; Biological SciencesAccumulation of microplastic on shorelines woldwide: Sources and sinks, Environmental Science & Technology (Washington), vol.45, 21, 2011,pp 9175-9179
2003Accuracy of the Australian National Death Index: comparison with adjudicated fatal outcomes among Australian participants in the long-term intervention with Pravastatin in Ischaemic Disease (LIPID) StudyKirby, Adrienne; Pater, Helen; Simes, Robert John; Hunt, David; Liew, Danny; Magliano, Dianna; Sundararajan, Vijaya; Tonkin, Andrew; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreAccuracy of the Australian National Death Index: comparison with adjudicated fatal outcomes among Australian participants in the long-term intervention with Pravastatin in Ischaemic Disease (LIPID) Study, Australian and New Zealand Journal of Public Health, vol.27,(6),2003,pp 649-653
2012Aspirin for the prevention of cognitive decline in the elderly: rationale and design of a neuro-vascular imaging study (ENVIS-ion)Wang, Jie Jin; Abhayaratna, Walter; Budge, Marc; Essex, Rowan; Janke, Andrew; Kam, Anthony; Reid, Christopher; Storey, Elsdon; Tonkin, Andrew; Wong, Tien; Woods, Robyn; Western Clinical School: Westmead Millennium InstituteAspirin for the prevention of cognitive decline in the elderly: rationale and design of a neuro-vascular imaging study (ENVIS-ion), BMC Neurology, vol.12, N/A, 2012,pp 1-9
2014Association of Contemporary Sensitive Troponin I Levels at Baseline and Change at 1 Year With Long - Term Coronary Events Following Myocardial Infarction or Unstable AnginaKeech, Anthony (Tony); Mann, Kristy; Simes, Robert John; Blankenberg, Stefan; Colquhoun, David; Hunt, David; Nestel, Paul; Stewart, Ralph A.H.; Sullivan, David; Thompson, Peter; Tonkin, Andrew; West, Malcolm; White, Harvey D.; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreAssociation of Contemporary Sensitive Troponin I Levels at Baseline and Change at 1 Year With Long - Term Coronary Events Following Myocardial Infarction or Unstable Angina, Journal of the American College of Cardiology, vol.63, 4, 2014,pp 345-354
2010AUSDRISK: an Australian Type 2 Diabetes Risk Assessment Tool based on demographic, lifestyle and simple anthropometric measuresColagiuri, Stephen; Mitchell, Paul; Balkau, Beverley; Chen, L; Magliano, D J; Phillips, Patrick; Shaw, J E; Tonkin, Andrew; Zimmet, Paul Z; Boden Institute; Western Clinical School: Westmead Institute for Medical ResAUSDRISK: an Australian Type 2 Diabetes Risk Assessment Tool based on demographic, lifestyle and simple anthropometric measures, Medical Journal of Australia, vol.192, 4, 2010,pp 197-202
2015Biomarkers in stable coronary heart disease, their modulation and cardiovascular risk: The LIPID biomarker studyHague, Wendy; Keech, Anthony (Tony); Kirby, Adrienne; Simes, Robert John; Sullivan, David; Blankenberg, Stefan; Colquhoun, David; Funke-Kaiser, Anne; Hunt, David; Nestel, P; Stewart, Ralph; Thompson, Peter; Tonkin, Andrew; West, Malcolm; White, Harvey; Zeller, Tanja; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentreBiomarkers in stable coronary heart disease, their modulation and cardiovascular risk: The LIPID biomarker study, International Journal of Cardiology, vol.201, N/A, 2015,pp 499-507
2013Changes in lipoprotein-associated phospholipase A2 activity predict coronary events and partly account for the treatment effect of pravastatin: results from the Long-Term Intervention with Pravastatin in Ischemic Disease studyBarnes, Elizabeth; Keech, Anthony (Tony); Marschner, Ian (Colin); Simes, Robert John; Sullivan, David; Blankenberg, Stefan; Colquhoun, David; Hunt, David; Nestel, Paul; Stewart, Ralph A.H.; Thompson, Peter; Tonkin, Andrew; West, Malcolm; White, Harvey D.; Zeller, Tanja; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreChanges in lipoprotein-associated phospholipase A2 activity predict coronary events and partly account for the treatment effect of pravastatin: results from the Long-Term Intervention with Pravastatin in Ischemic Disease study, Journal of the American Heart Association, vol.2, 5, 2013,pp 1-12
2012Comparative Effectiveness of Population Interventions to Improve Access to Reperfusion for ST-Segment-Elevation Myocardial Infarction in AustraliaBrieger, David; Ranasinghe, Isuru; Turnbull, Fiona; Clark, Robyn; Coffee, Neil; Tonkin, Andrew; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: Medicine; The George Institute for International HealthComparative Effectiveness of Population Interventions to Improve Access to Reperfusion for ST-Segment-Elevation Myocardial Infarction in Australia, Circulation. Cardiovascular Quality and Outcomes, vol.5, 4, 2012,pp 429-436
2010Coronary disease in indigenous populations: summary from the CSANZ indigenous Cardiovascular Health ConferenceBrieger, David; Jeremy, Richmond; Kritharides, Leonard; Brown, Alex; Riddell, Tania; Tonkin, Andrew; Walsh, Warren; White, Harvey D.; Zeitz, Chris; Concord Clinical School: ANZAC Research Institute; Central Clinical School: Medicine; Concord Clinical School: ANZAC Research InstituteCoronary disease in indigenous populations: summary from the CSANZ indigenous Cardiovascular Health Conference, Heart, Lung & Circulation (Online), vol.19, 5-6,pp 299-305
2006Cost-effectiveness of cholesterol-lowering therapy with pravastatin in patients with previous acute coronary syndromes aged 65 to 74 years compared with younger patients: results from the LIPID study.Eckermann, Simon; Glasziou, Paul; Kirby, Adrienne; Mulray, Sarah; Simes, Robert John; Denton, Mary; Friedlander, D; Hunt, David; LIPID, S u; Magnus, Paul; Sallaberger, Michele; Tonkin, Andrew; White, Harvey D.; School of Public Health: NH&MRC Clinical Trials Centre; Medicine; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreCost-effectiveness of cholesterol-lowering therapy with pravastatin in patients with previous acute coronary syndromes aged 65 to 74 years compared with younger patients: results from the LIPID study., American Heart Journal, vol.151,(6),2006,pp 1305-1312
2017Development of an Australian cardiovascular disease mortality risk score using multiple imputation and recalibration from national statisticsColagiuri, Stephen; Gopinath, Bamini; Hirakawa, Yoichiro; Mitchell, Paul; Woodward, Mark; Backholer, Kathryn; Giles, Graham; Harding, J; Harris, M; Magliano, D J; Nelson, Mark; Shaw, Jonathan; Simmons, D; Simons, L; Taylor, A; Tonkin, Andrew; Boden Institute; Western Clinical School: Clinical Ophthal & Eye Health; The George Institute for Global Health; Western Clinical School: Westmead Institute for Medical Res; The George Institute for Global HealthDevelopment of an Australian cardiovascular disease mortality risk score using multiple imputation and recalibration from national statistics, BMC Cardiovascular Disorders, vol.17, 1, 2017,pp 1-9
2002Dose-dependent effects of folic acid on plasma homocysteine in a randomized trial conducted among 723 individuals with coronary heart diseaseKeech, Anthony (Tony); MacMahon, Stephen; Neal, Bruce; Ohkubo, Takayoshi; Tonkin, Andrew; Wilcken, David E.; School of Public Health: NH&MRC Clinical Trials Centre; The George Institute for International Health; The George Institute for International Health; Medicine; Medicine Faculty OfficeDose-dependent effects of folic acid on plasma homocysteine in a randomized trial conducted among 723 individuals with coronary heart disease, European Heart Journal, vol.23,(19),2002,pp 1509-1515
2015The Effect of a Cardiovascular Polypill Strategy on Pill BurdenBompoint, Severine; Patel, Anushka; Peiris, David; Rodgers, Anthony; Truelove, Michael; Usherwood, Timothy; Webster, Ruth; Brown, Alex; Crass, Alan; Hillis, Graham; Rafter, Natasha; Reid, Chris; Tonkin, Andrew; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global Health; School of Public Health: Medicine; Western Clinical School: General Practice; The George Institute for Global HealthThe Effect of a Cardiovascular Polypill Strategy on Pill Burden, Cardiovascular Therapeutics, vol.33, 6, 2015,pp 347-352
2005Effect of pravastatin in people with chronic kidney disease and diabetes mellitus.Keech, Anthony (Tony); Simes, Robert John; Craven, Timothy; Curhan, Gary; Furberg, Curt D; Isles, Chris; Packard, Chris; Pfeffer, Marc A; Sacks, Frank M; Shepherd, Jim; Tonelli, Marcello; Tonkin, Andrew; West, Malcolm; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreEffect of pravastatin in people with chronic kidney disease and diabetes mellitus., Hypertension 2005, vol.46,(4),2005,pp 900-901
2005Effect of pravastatin in people with diabetes and chronic kidney disease.Keech, Anthony (Tony); Simes, Robert John; et, al; Furberg, C; Isles, Chris; Packard, Chris; Pfeffer, M; Sacks, Frank; Shepherd, Jim; Tonelli, Marcello; Tonkin, Andrew; West, Malcolm; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreEffect of pravastatin in people with diabetes and chronic kidney disease., Journal of the American Society of Nephrology, vol.16,(12),2005,pp 3748-3754
2003Effect of pravastatin on cardiovascular events and mortality in 1516 women with coronary heart disease: Results from the Long-Term Intervention with Pravastatin in Ischemic Disease (LIPID) studyForder, Peta; Hague, Wendy; Simes, Robert John; Tonkin, Andrew; Hunt, David; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; Medicine Faculty OfficeEffect of pravastatin on cardiovascular events and mortality in 1516 women with coronary heart disease: Results from the Long-Term Intervention with Pravastatin in Ischemic Disease (LIPID) study, American Heart Journal, vol.145,(4),2003,pp 643-651
2005Effect of pravastatin on rate of kidney function loss in people with or at risk for coronary disease.Simes, Robert John; Cobbe, Stuart M; Craven, Timothy; et, al; Furberg, C; Isles, Chris; Pfeffer, M; Sacks, Frank; Shepherd, James; Tonelli, Marcello; Tonkin, Andrew; School of Public Health: NH&MRC Clinical Trials CentreEffect of pravastatin on rate of kidney function loss in people with or at risk for coronary disease., Circulation 2005, vol.112,(2),2005,pp 171-178
2011Effects of Beta-adrenergic antagonists in patients with chronic kidney disease a systematic review and meta-analysisCass, Alan; Perkovic, Vlado; Badve, Sunil V.; Garg, Amit X.; Hawley, Carmel; Krum, Henry; Roberts, Matthew A.; Tonkin, Andrew; School of Public Health: Medicine; The George Institute for Global HealthEffects of Beta-adrenergic antagonists in patients with chronic kidney disease a systematic review and meta-analysis, Journal of the American College of Cardiology, vol.58, 11, 2011,pp 1152-1161
2012Effects of fenofibrate on cardiovascular events in patients with diabetes, with and without prior cardiovascular disease: The Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) studyForder, Peta; Keech, Anthony (Tony); Simes, Robert John; Voysey, Merryn; Glasziou, Paul; Hamer, Andrew; Hunt, David; Kesaniemi, Y. Antero; Mahar, Leo; Mann, Stewart; Tonkin, Andrew; Waites, Jonathon H; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreEffects of fenofibrate on cardiovascular events in patients with diabetes, with and without prior cardiovascular disease: The Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study, American Heart Journal, vol.163, 3, 2012,pp 508-514
2004Effects Of Pravastatin On Coronary Events In 2073 Patients With Low Levels Of Both Low-Density Lipoprotein Cholesterol And High-Density Lipoprotein Cholesterol: Results From The Lipid Study.Barter, Philip; Keech, Anthony (Tony); Marschner, Ian; Simes, Robert John; Colquhoun, David; Glasziou, Paul; Hunt, David; Tonkin, Andrew; White, Harvey D.; Central Clinical School: Medicine; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreEffects Of Pravastatin On Coronary Events In 2073 Patients With Low Levels Of Both Low-Density Lipoprotein Cholesterol And High-Density Lipoprotein Cholesterol: Results From The Lipid Study., European Heart Journal (2005), vol.25,(9),2004,pp 771-777